Clinical Trial Update: Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1 [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates topical Imiquimod 5% cream for treating cutaneous neurofibromas in adults with Neurofibromatosis Type 1; the trial status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Neurofibromas
• Neurofibromatosis Type

Drugs mentioned

• Imiquimod 5% cream (Imiquimod)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Neurofibromatosis Type 1, Cutaneous Neurofibromas | Phase 1 | Status: COMPLETED